Helen Louise Collins - Nov 15, 2023 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role
Director
Signature
/s/ Brian Burkavage, Attorney-in-Fact for Helen Louise Collins
Stock symbol
IOBT
Transactions as of
Nov 15, 2023
Transactions value $
$0
Form type
4
Date filed
11/17/2023, 04:47 PM
Previous filing
Nov 17, 2023
Next filing
Feb 15, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOBT Stock Option (Right to Buy) Award $0 +64.2K $0.00 64.2K Nov 15, 2023 Common Stock 64.2K $0.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of these options vest each month over three years, subject to the reporting person's continued service through each applicable vesting date, and subject to 100% acceleration upon a change of control.